Current Cancer Therapy Reviews
Title:Review of Patent Series eBook "Topics in Anti-Cancer Research, Volume 6, 2017"
Volume: 15 Issue: 1
Author(s): Alexander A. Shtil
Affiliation:
Export Options
About this article
Cite this article as:
Shtil A. Alexander, Review of Patent Series eBook "Topics in Anti-Cancer Research, Volume 6, 2017", Current Cancer Therapy Reviews 2019; 15 (1) . https://dx.doi.org/10.2174/1573394714666180621144333
DOI https://dx.doi.org/10.2174/1573394714666180621144333 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
49
3
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Functional Genome-wide Analysis: a Technical Review, Its Developments and Its Relevance to Cancer Research
Recent Patents on DNA & Gene Sequences Drug Design for Protein Kinases and Phosphatases: Flexible-Receptor Docking, Binding Affinity and Specificity, and Drug-Binding Kinetics
Current Pharmaceutical Design Pharmacokinetics and Disposition of Nanomedicine Using Biodegradable PEG/PCL Polymers as Drug Carriers
Current Drug Metabolism Vascular Resection in Pancreaticoduodenectomy: Is it Worthwhile?
Current Drug Targets From Amino Acids to Proteins as Targets for Metal-based Drugs
Current Drug Metabolism Isolation of Bioactive Natural Products from Myxomycetes
Medicinal Chemistry Nanocarriers Assisted siRNA Gene Therapy for the Management of Cardiovascular Disorders
Current Pharmaceutical Design The Design of Cationic Lipids for Gene Delivery
Current Pharmaceutical Design Quantification of SPECT and PET for Drug Development
Current Radiopharmaceuticals Novel Substituted Quinazolines for Potent EGFR Tyrosine Kinase Inhibitors
Current Medicinal Chemistry The Promise of Dolutegravir: A Novel Second Generation Integrase Strand Transfer Inhibitor
Current Clinical Pharmacology Cdc20: A Potential Novel Therapeutic Target for Cancer Treatment
Current Pharmaceutical Design Ocular Inflammatory Diseases: Molecular Pathogenesis and Immunotherapy
Current Molecular Medicine Modification of Tumor Microenvironment Utilizing Nanotechnology Advancement for Better Therapeutic Effect
Nanoscience & Nanotechnology-Asia Risk Assessment of the Use of Autonomous Parvovirus-Based Vectors
Current Gene Therapy Hybrid Imaging: Conclusions and Perspectives
Current Medical Imaging Liposomal Irinotecan in the Treatment of Refractory Pancreatic Cancer
Recent Patents on Anti-Cancer Drug Discovery Cancer Stem Cell Based Targeted Therapy
Current Pharmaceutical Design High Throughput Screening Technology and the Small Molecules Modulating Aging Related Signals
Combinatorial Chemistry & High Throughput Screening Deregulation of miR-21 and miR-29a in Cervical Cancer Related to HPV Infection
MicroRNA